These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8336506)

  • 21. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on aggregation of human platelets of two xanthines and their interactions with adenosine.
    Vinge E; Andersson KE; Persson CG
    Acta Physiol Scand; 1984 Jan; 120(1):117-21. PubMed ID: 6326472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasopressin-induced activation of human blood platelets: prominent role of Mg2+.
    Erne P; Pletscher A
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Mar; 329(1):97-9. PubMed ID: 3158825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactions of polylysine with human platelets in plasma and in suspensions of washed platelets.
    Guccione MA; Packham MA; Kinlough-Rathbone RL; Perry DW; Mustard JF
    Thromb Haemost; 1976 Nov; 36(2):360-75. PubMed ID: 827032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collagen-induced platelet aggregation:--evidence against the essential role of platelet adenosine diphosphate.
    Nunn B
    Thromb Haemost; 1979 Dec; 42(4):1193-206. PubMed ID: 542929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion.
    White JG; Rao GH; Gerrard JM
    Am J Pathol; 1974 Nov; 77(2):135-49. PubMed ID: 4374890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG; Frojmovic MM; Tang SS; White JG
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR; Colley DG; Des Prez RM
    J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation.
    Donato JL; Marcondes S; Antunes E; Nogueira MD; Nader HB; Dietrich CP; Rendu F; de Nucci G
    Br J Pharmacol; 1996 Dec; 119(7):1447-53. PubMed ID: 8968554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
    Michal F; Motamed M
    Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiologic concentrations of arginine vasopressin activate human platelets in vitro.
    Wun T; Paglieroni T; Lachant NA
    Br J Haematol; 1996 Mar; 92(4):968-72. PubMed ID: 8616095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tumor-promoter phorbol ester (12-O-tetradecanoyl-phorbol-13-acetate), a potent aggregating agent for blood platelets.
    Zucker MB; Troll W; Belman S
    J Cell Biol; 1974 Feb; 60(2):325-36. PubMed ID: 4360292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal variation in melatonin effect on adenosine triphosphate and serotonin release by human platelets.
    Del Zar MM; Martinuzzo M; Cardinali DP; Carreras LO; Vacas MI
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):453-8. PubMed ID: 2239090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y
    Boncler M; Wzorek J; Wolska N; Polak D; Watala C; Rozalski M
    Vascul Pharmacol; 2019 Feb; 113():47-56. PubMed ID: 30471364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release, aggregation and lysis of human platelets by antilymphocyte globulin and antiplatelet serum.
    Lekas N; Rosenberg JC
    Thromb Haemost; 1976 Nov; 36(2):411-23. PubMed ID: 1087479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma and platelet vasopressin in essential hypertension and congestive heart failure.
    Preibisz JJ; Sealey JE; Laragh JH; Cody RJ; Weksler BB
    Hypertension; 1983; 5(2 Pt 2):I129-38. PubMed ID: 6826223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.